Your email has been successfully added to our mailing list.

×
0 0 0 0 -0.012072434607646 -0.012072434607646 -0.0160965794768612 -0.0160965794768612
Stock impact report

FDA grants RMAT tag for Magenta cell therapy for inherited metabolic disorders [Seeking Alpha]

Magenta Therapeutics, Inc. (MGTA) 
Last magenta therapeutics, inc. earnings: 11/13 08:00 am Check Earnings Report
Company Research Source: Seeking Alpha
FDA grants RMAT tag for Magenta cell therapy for inherited metabolic disorders - Magenta Therapeutics, Inc. (NASDAQ:MGTA) | Seeking Alpha Healthcare FDA grants RMAT tag for Magenta cell therapy for inherited metabolic disorders Sep. 4, 2019 9:47 AM ET | Magenta Therapeutics, ... (MGTA) Douglas W. House The FDA designates +1.3% RMAT is akin to Breakthrough Therapy status for drugs/biologics. It provides for the accelerated review of the marketing application and more intensive guidance on development. Phase 2-stage MGTA-456 is designed to stop the progress of the metabolic disorders by providing a high dose of stem cells that regenerate a new immune system in the patient. Click to subscribe to real-time analytics on MGTA Now read: ADMA: Ready To Capitalize On The IVIG Shortage » Subscribe Show less Read more
Impact Snapshot
Event Time:
MGTA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for MGTA alerts
Opt-in for
MGTA alerts

from News Quantified
Opt-in for
MGTA alerts

from News Quantified